drugset / Trial / NCT02351960
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effectiveness of symptom control in gastroesophageal reflux disease (GERD) participants following treatment with dexlansoprazole.
Timeline
- Start
- 2015-03-19
- Primary completion
- 2016-06-22
- Completion
- 2016-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexlansoprazole | Other / unclassified | 30 mg | Oral |
| Subject | Dexlansoprazole | Other / unclassified | 60 mg | Oral |